^
Association details:
Biomarker:PARP1 overexpression
Cancer:Breast Cancer
Drug:Lynparza (olaparib) (PARP inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: D – Preclinical
New
Source:
Title:

Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib

Excerpt:
ALDH+ cells from BRCA1-mutated HCC1937, which had the highest level of PARP1 overexpression, displayed resistance to olaparib, a specific PARP1 inhibitor.
DOI:
10.1371/journal.pone.0104302